Weight loss under the action of GLP-1RA is not only caused by acting on the hypothalamus or parasympathetic nervous system, thereby inhibiting appetite and delaying gastric emptying, but also by acting on white and brown adipocytes.40 GLP-1RA can promote browning of white adipocytes in mice through fat breakdown and oxidation, significantly reducing fat content.41 Yahui Zhang et al found that GLP-1RA can alleviate hyperinsulinemia and hyperandrogenism in PCOS mice by reducing inflammation of white adipose tissue and stimulating browning of white adipose tissue.42 Xiong et al confirmed that semaglutide modulated the diversity of gut microbiota in PCOS patients.43 Previous clinical trials have shown that both metformin and metformin combined with liraglutide can improve the menstrual cycle, weight, and glucose metabolism in obese PCOS patients
The tirzepatide dose of 10 mg was next (mean difference of 1.86%), followed by semaglutide 2 mg (mean difference of 1.62%)
Aug 10 2020;10(8)doi:10.3390/ani10081385
cerana cerana when exposed to varying temperatures and H 2 O 2, suggesting a protective function against oxidative stress [132]
Semaglutide side effects are primarily gastrointestinal (nausea, digestive issues)
Specifically, people with diabetes were more prone to invasive mechanical ventilation, admission in the ICU and development of acute kidney injury, as compared with patients without diabetes [6]